Pamidronic acid
CAS: 40391-99-9
Ref. 3D-FP32121
25mg | 136,00 € | ||
50mg | 192,00 € | ||
100mg | 282,00 € | ||
250mg | 454,00 € | ||
500mg | 633,00 € |
Información del producto
- (3-Amino-1-Hydroxypropane-1,1-Diyl)Bis(Phosphonic Acid)
- (3-Amino-1-Hydroxypropylidene)Bisphosphonic Acid
- (3-Amino-1-hydroxy-1-phosphonopropyl)phosphonic acid
- (3-Amino-1-hydroxypropyliden)bisphosphonsaure
- (3-Amino-1-hydroxypropylidene)-1,1-bisphosphonate
- (α-Hydroxy-γ-aminopropylidene)diphosphonic acid
- 1-Hydroxy-3-aminopropane-1,1-diphosphonic acid
- 3-Amino-1-hydroxypropane-1,1-diphosphonic acid
- 3-Amino-1-hydroxypropylidene-1,1-bisphosphonic acid
- 3-Amino-1-hydroxypropylidenediphosphonic acid
- Ver más sinónimos
- ADP
- AHPrBP
- Acide (3-Amino-1-Hydroxypropylidene)Bisphosphonique
- Acido (3-Amino-1-Hidroxipropiliden)Bisfosfonico
- Amidronic acid
- Bph 5
- P,P′-(3-Amino-1-hydroxypropylidene)bis[phosphonic acid]
- Panolin
- Phosphonic acid, P,P'-(3-amino-1-hydroxypropylidene)bis-
- Propane-1-hydroxy-3-amino-1,1-diphosphonic acid
- Pamidronate
- Phosphonic acid, (3-amino-1-hydroxypropylidene)bis-
Pamidronic acid is a monosodium salt that inhibits the production of proteins by binding to the enzyme protein phosphatase. It has been shown to be an effective chemotherapeutic treatment in a number of animal models and human clinical trials for various cancers, including myeloma, squamous carcinoma, and bone cancer. Pamidronic acid also prevents the proliferation of tumor cells in culture via inhibition of DNA synthesis and RNA synthesis. This drug binds to estrogen receptors on the surface of some cancer cells, thereby inhibiting their response to estradiol benzoate (EB) stimulation. This leads to decreased tumor growth in preclinical models.
Propiedades químicas
Consulta técnica sobre: 3D-FP32121 Pamidronic acid
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.